- Does it seem possible to be able to improve patient care and generate savings?
- Can QIPP be turned in to a medium for joint working with commissioners and the pharmaceutical industry?
- Will the patient-centric objectives of medicines optimisation be met within QIPP and care enhanced?
Val Shaw of Cambridge University Hospitals Trust is coming to the Forum to share experiences in delivering successful outcomes for all parties.
“Medicines Optimisation-can it offer a QIPP/CIP opportunity”
Book your place now at www.pharmanforum.co.uk